Zeposia Tablets Approved in Scotland to Treat Active RRMS
News, Zeposia
The Scottish Medicines Consortium (SMC) has approved Zeposia (ozanimod) for the treatment of active relapsing-remitting multiple sclerosis (RRMS). Zeposia is sold as a tablet, to be taken by mouth once daily. The ... Read more